In vitro cell killing assays demonstrated selectivity of DHES0815A for HER2+ BC cells (SK-BR-3), with no activity on HER2-negative (HER2-) MCF7 (Fig. 2a) or MDA-MB-468 cells (Supplementary Fig. 6a). The gene discussed is ERBB2; the disease is breast cancer.